Prices as of 2025-12-02 16:20:44 ET
Ticker Appearances
Signal From Noise
AI: The New Sovereigns and Agents
In August 2023, as the AI craze was settling in for a sustained surge, _The New York Times_ did a piece on Nvidia. Naveen Rao,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: e9cf4a-cd0d76-5238c4-6c8185-ef53c2 Array ( [cookie] => e9cf4a-cd0d76-5238c4-6c8185-ef53c2 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.91 )
Daily Technical Strategy
Small caps have appeal after recent pullback; Biotechnology favored within Healthcare
TUNE IN TO CNBC AT 8:00AM EST FRIDAY 1/5 TO CATCH ME ON SQUAWK BOX. TECHNICALLY, OUR RECENT CONSOLIDATION IN US RISK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: e9cf4a-cd0d76-5238c4-6c8185-ef53c2 Array ( [cookie] => e9cf4a-cd0d76-5238c4-6c8185-ef53c2 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.91 )
Signal From Noise
AI: The New Sovereigns and Agents
In August 2023, as the AI craze was settling in for a sustained surge, _The New York Times_ did a piece on Nvidia. Naveen Rao,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: e9cf4a-cd0d76-5238c4-6c8185-ef53c2 Array ( [cookie] => e9cf4a-cd0d76-5238c4-6c8185-ef53c2 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.91 )
Daily Technical Strategy
Small caps have appeal after recent pullback; Biotechnology favored within Healthcare
TUNE IN TO CNBC AT 8:00AM EST FRIDAY 1/5 TO CATCH ME ON SQUAWK BOX. TECHNICALLY, OUR RECENT CONSOLIDATION IN US RISK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: e9cf4a-cd0d76-5238c4-6c8185-ef53c2 Array ( [cookie] => e9cf4a-cd0d76-5238c4-6c8185-ef53c2 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.91 )
Not Available
Articles Read 0/2
🎁 Unlock 1 extra article by joining our Community!
Stay up to date with the latest articles. You’ll even get special recommendations weekly.
Already have an account? Sign In e9cf4a-cd0d76-5238c4-6c8185-ef53c2
Already have an account? Sign In e9cf4a-cd0d76-5238c4-6c8185-ef53c2
